Background: Chronic pulmonary infection with pathogens such as Pseudomonas aeruginosa is associated with lung function decline and increased mortality in people with cystic fibrosis (CF). The relationship between sputum bacterial load and the severity of pulmonary exacerbations remains unclear. This study aimed to explore the relationship between sputum bacterial load and clinical response to antibiotic treatment of pulmonary exacerbations in children with CF.
View Article and Find Full Text PDFLeukemia patients who receive chemotherapy experience a decline in neutrophils and an increased risk of infections. Neutropenic sepsis is a life-threatening condition and a major cause of cancer-related mortality. Patients with neutropenic sepsis are generally treated with Broad Spectrum Antibiotics (BSA) as a first-line medication that destroys common causative organisms but may either miss the true pathogen or be overly broad leading to an increased risk of development of Antimicrobial Resistance (AMR).
View Article and Find Full Text PDFSeveral gut peptides have been implicated in feeding and body mass accumulation. Glucagon-like peptide 1 (GLP-1) and peptide tyrosine-tyrosine (PYY) have been shown to mediate satiety and reduce food intake. While systemic administration of such peptides has been explored as a therapy for metabolic disease, the effects of these hormones on taste signaling should also be considered given the importance of taste to feeding decisions and considering the fact that components of these signaling systems are expressed in cells of the peripheral gustatory system.
View Article and Find Full Text PDFLectins are a heterogeneous group of carbohydrate-binding proteins that vary in size, structure, molecular organization, and binding patterns. They evoke diverse biological responses by specifically binding to cell surface glycans and function as recognition molecules. In this study, a lectin from the fruit of Phyllanthus reticulatus was purified using mucin-affinity chromatography.
View Article and Find Full Text PDFThe advent of automated insulin delivery (AID) systems in 2020 marked a disruptive event in managing type 1 diabetes, benefiting children and adults alike. By 2024, advances in real-world data and research motivated an update to the French consensus on AID systems to expand accessibility, refine guidelines, and optimize patient follow-up. AID systems have consistently improved glycemic control by reducing HbA1c, increasing time-in-range (TIR), and minimizing hypoglycemia, with significant benefits even for specific populations such as individuals with poor glycemic control, brittle diabetes, children, very young children, pregnant women, those with insulin resistance or gastroparesis, or after bariatric surgery.
View Article and Find Full Text PDF